Cargando…

The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants

BACKGROUND: Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Czech-Kowalska, Justyna, Czekuc-Kryskiewicz, Edyta, Pludowski, Pawel, Zaniuk, Katarzyna, Jaworski, Maciej, Łuba, Anna, Grzybowska, Karolina, Piłat, Krystyna, Dobrzanska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091911/
https://www.ncbi.nlm.nih.gov/pubmed/27806112
http://dx.doi.org/10.1371/journal.pone.0165727
_version_ 1782464657157521408
author Czech-Kowalska, Justyna
Czekuc-Kryskiewicz, Edyta
Pludowski, Pawel
Zaniuk, Katarzyna
Jaworski, Maciej
Łuba, Anna
Grzybowska, Karolina
Piłat, Krystyna
Dobrzanska, Anna
author_facet Czech-Kowalska, Justyna
Czekuc-Kryskiewicz, Edyta
Pludowski, Pawel
Zaniuk, Katarzyna
Jaworski, Maciej
Łuba, Anna
Grzybowska, Karolina
Piłat, Krystyna
Dobrzanska, Anna
author_sort Czech-Kowalska, Justyna
collection PubMed
description BACKGROUND: Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. AIM: To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). MATERIALS AND METHODS: Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, cross-linked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (≤ 34 weeks’ gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. RESULTS: The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr ≤0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. CONCLUSION: Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants.
format Online
Article
Text
id pubmed-5091911
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50919112016-11-15 The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants Czech-Kowalska, Justyna Czekuc-Kryskiewicz, Edyta Pludowski, Pawel Zaniuk, Katarzyna Jaworski, Maciej Łuba, Anna Grzybowska, Karolina Piłat, Krystyna Dobrzanska, Anna PLoS One Research Article BACKGROUND: Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. AIM: To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). MATERIALS AND METHODS: Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, cross-linked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (≤ 34 weeks’ gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. RESULTS: The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr ≤0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. CONCLUSION: Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants. Public Library of Science 2016-11-02 /pmc/articles/PMC5091911/ /pubmed/27806112 http://dx.doi.org/10.1371/journal.pone.0165727 Text en © 2016 Czech-Kowalska et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Czech-Kowalska, Justyna
Czekuc-Kryskiewicz, Edyta
Pludowski, Pawel
Zaniuk, Katarzyna
Jaworski, Maciej
Łuba, Anna
Grzybowska, Karolina
Piłat, Krystyna
Dobrzanska, Anna
The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
title The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
title_full The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
title_fullStr The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
title_full_unstemmed The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
title_short The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
title_sort clinical and biochemical predictors of bone mass in preterm infants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091911/
https://www.ncbi.nlm.nih.gov/pubmed/27806112
http://dx.doi.org/10.1371/journal.pone.0165727
work_keys_str_mv AT czechkowalskajustyna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT czekuckryskiewiczedyta theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT pludowskipawel theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT zaniukkatarzyna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT jaworskimaciej theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT łubaanna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT grzybowskakarolina theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT piłatkrystyna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT dobrzanskaanna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT czechkowalskajustyna clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT czekuckryskiewiczedyta clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT pludowskipawel clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT zaniukkatarzyna clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT jaworskimaciej clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT łubaanna clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT grzybowskakarolina clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT piłatkrystyna clinicalandbiochemicalpredictorsofbonemassinpreterminfants
AT dobrzanskaanna clinicalandbiochemicalpredictorsofbonemassinpreterminfants